Cash management is critical for pharmaceutical companies: The ability to fund drug innovation can make the difference between ...

This effort, undertaken by Bristol Myers Squibb and agency partner Real Chemistry, is part of the Champions in Care campaign.

In early January 2026, UBS upgraded Bristol-Myers Squibb after highlighting its broad drug pipeline, new clinical trial ...

Brady Middle School eighth-graders took to the gym floor earlier this school year to demonstrate the skills the students ...

LAS VEGAS, NV, UNITED STATES, January 6, 2026 / EINPresswire.com / — Electra Vehicles, the leader in AI-driven battery ...

After receiving a determination from the Department of War/Defense, the FCC updated its ban on foreign-made drones and ...

A few 2025 trials pointed in the same direction: toward treatments built to modify disease biology and better ways to measure ...

Dark Blue Therapeutics ("Dark Blue"), a discovery and development biotech company pioneering the next generation of precision oncology medicines, has been acquired by Amgen (NASDAQ: AMGN).

New analysis of a Phase 3 study of daridorexant shows that 50 mg improved both sleep and daytime functioning compared to placebo in women during ...

Amgen’s acquisition of Dark Blue Therapeutics adds a first-in-class leukemia program that aligns with the company’s growing ...

Kooltech announces the launch of the KS1-BR41N, a new addition to their K-con bespoke solutions range. Also known as K-BRAIN, ...

California healthcare innovator Amgen, which already has facilities at Cambridge Science Park, has made a new and incisive acquisition in the UK - buying Oxford University spin-out Dark Blue ...